Science Inventory

<< Previous

Kleensang, A., A. Maertens, M. Rosenberg, S. Fitzpatrick, J. Lamb, S. Auerbach, R. Brennan, K. Crofton, B. Gordon, A. Fornance, K. Gaido, D. Gerhold, R. Haw, A. Henney, A. Ma’ayan, M. McBride, S. Monti, M. Ochs, A. Pandey, R. Sharan, R. Stierum, S. Tugendreich, C. Willett, C. Wittwehr, J. Xia, G. Patton, K. Arvidson, M. Bouhifd, H. Hogberg, T. Luechtefeld, L. Smirnova, L. Zhao, Y. Adeleye, M. Kanehisa, P. Carmichael, M. Andersen, AND T. Hartung. Pathways of Toxicity. ALTEX. Society ALTEX Edition, Kuesnacht, Switzerland, 31(1):53-61, (2014).

Lynn, S., M. Hornung, M. Gilbert, AND K. Crofton. Strengthening the ability to screen for thyroid disrupting chemicals under EDSP. SETAC, Vancouver, BC, CANADA, November 09 - 13, 2014.

Edwards, S., C. Wittwehr, H. Aladjov, E. Perkins, N. Garcia-Reyero, G. Ankley, D. Lyons, T. Habib, J. DeKnecht, S. Munn, B. Landesmann, M. Whelan, K. Crofton, AND Dan Villeneuve. The adverse outcome pathway knowledge base. SETAC, Vancouver, BC, CANADA, November 09 - 13, 2014.

Paul, K., J. Hedge, D. Rotroff, K. Crofton, M. Hornung, AND Steve Simmons. Using adverse outcome pathway analysis to guide development of high-throughput screening assays for thyroid-disruptors. Presented at CCT/SOT MEETING, Chapel Hill, NC, January 16 - 17, 2014.

Gilbert, M., J. Hedge, L. Valentin-Blasini, B. Blount, K. Kannan, Joe Tietge, R. Zoeller, K. Crofton, J. Jarrett, AND J. Fisher. An animal model of marginal iodine deficiency during development: The thyroid axis and neurodevelopmental outcome. Presented at Society of Toxicology meeting, March 10 - 14, 2013.

Gilbert, M., J. Hedge, L. Valentin-Blasini, B. Blount, K. Kannan, Joe Tietge, R. Zoeller, K. Crofton, J. Jarrett, AND J. Fisher. An animal model of marginal iodine deficiency during development: The thyroid axis and neurodevelopmental outcome. ##. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 132(1):177-95, (2013).

Paul, K., J. Hedge, C. Macherla, D. Filer, E. Burgess, Steve Simmons, K. Crofton, AND M. Hornung. Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat. TOXICOLOGY. Elsevier Science Ltd, New York, NY, 312:97-107, (2013).

Perkins, E., G. Ankley, K. Crofton, N. Garcia-Reyero, C. LaLone, M. Johnson, Joe Tietge, AND Dan Villeneuve. Current perspectives on the use of alternative species in human health and ecological hazard assessments. ENVIRONMENTAL HEALTH PERSPECTIVES. National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, 121(9):1002-1010, (2013).

Hughes, M., D. Ross, J. Starr, E. Scollon, M. Wolansky, K. Crofton, AND M. DeVito. Dose-response relationship of an environmental mixture of pyrethroids following an acute oral administration in the rat. Presented at Society of Toxicology, March 10 - 14, 2013.

Fisher, J., M. E. GILBERT, K. M. CROFTON, T. Zoeller, E. MCLANAHAN, A. Lumen, AND S. Li. Evaluation Of Iodide Deficiency In The Lactating Rat And Pup Using A Biologically Based Dose Response (BBDR) Model. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 132(1):75-86, (2013).

Fisher, J., L. Shaung, K. Crofton, R. Zoeller, E. McLanahan, A. Lumen, AND M. Gilbert. Evaluation of iodide deficiency in the lactating rat and pup using a biologically based dose response (BBDR) Model***. Presented at Society of Toxicology meeting, March 10 - 14, 2013.

Fisher, J., S. Li, K. Crofton, R. Zoeller, E. McLanahan, A. Lumen, AND M. Gilbert. Evaluation of iodide deficiency in the lactating rat and pup using a biologically based dose-response model. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 132(1):75-86, (2013).

Paul, K., J. Thompson, Steve Simmons, J. Vanden Heuvel, AND K. Crofton. Evidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptors. TOXICOLOGY IN VITRO. Elsevier Science Ltd, New York, NY, 27(7):2049-2060, (2013).

Villeneuve, Dan, S. Kennedy, E. Perkins, K. Tollefsen, K. Crofton, R. Kavlock, M. Whelan, AND A. Gourmelon. Overview of an internationally-harmonized program for adverse outcome pathway development. Presented at SETAC, Nashville, TN, November 17 - 21, 2013.